U.S. markets closed

Change Healthcare Inc. (CHNG)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
27.49+0.07 (+0.26%)
At close: 04:00PM EDT
27.55 +0.06 (+0.22%)
After hours: 05:57PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close27.42
Bid27.45 x 900
Ask27.55 x 1200
Day's Range27.43 - 27.55
52 Week Range18.97 - 27.59
Avg. Volume5,523,334
Market Cap9.025B
Beta (5Y Monthly)1.02
PE Ratio (TTM)N/A
EPS (TTM)-0.18
Earnings DateNov 01, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est27.31
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for CHNG

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Change Healthcare Inc.
    Analyst Report: Change Healthcare Inc.Change Healthcare is a spinoff of various healthcare processing and consulting services acquired by McKesson over numerous years. Recently, these processing assets were contributed to a joint venture and in June 2019 public shares were issued with McKesson retaining the majority interest. As of the end of the March 2020 quarter, McKesson distributed all its interest in the public processor. Core services consist of insurance (healthcare) claim clearinghouse for healthcare payers in addition to administrative and consulting services to assist healthcare providers improve reimbursement coding, billing, and collections.
    Fair Value
    Economic Moat
    13 days agoMorningstar
View more
  • The Wall Street Journal

    Justice Department Loses Antitrust Bid to Block Sugar Industry Merger

    A federal judge ruled U.S. Sugar can proceed with its planned purchase of rival Imperial Sugar, rejecting a Justice Department antitrust challenge.

  • Benzinga

    Raymond James Beefs Up UnitedHealth Price Target On Smoother Sailing Of Change Deal

    Raymond James reiterates a Strong Buy rating on UnitedHealth Group Inc (NYSE: UNH) while raising the price target to $635 from $620 as a U.S. judge gave a green signal for Change Healthcare Inc's (NASDAQ: CHNG) acquisition. The ruling ended a 21-month fight between UnitedHealth and regulators. The analyst John Ransom writes that the deal is expected to close within ten days of the judge's decision, but DOJ is "evaluating next steps," and there is a slight chance of an appeal and further delay. F

  • Zacks

    Company News for Sep 21, 2022

    Companies in The News Are: F,HUM,CHNG,UNH,CGNX